Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationWO1999013859 A1
Type de publicationDemande
Numéro de demandePCT/US1998/018804
Date de publication25 mars 1999
Date de dépôt10 sept. 1998
Date de priorité16 sept. 1997
Autre référence de publicationCA2270073A1, EP0952818A1
Numéro de publicationPCT/1998/18804, PCT/US/1998/018804, PCT/US/1998/18804, PCT/US/98/018804, PCT/US/98/18804, PCT/US1998/018804, PCT/US1998/18804, PCT/US1998018804, PCT/US199818804, PCT/US98/018804, PCT/US98/18804, PCT/US98018804, PCT/US9818804, WO 1999/013859 A1, WO 1999013859 A1, WO 1999013859A1, WO 9913859 A1, WO 9913859A1, WO-A1-1999013859, WO-A1-9913859, WO1999/013859A1, WO1999013859 A1, WO1999013859A1, WO9913859 A1, WO9913859A1
InventeursGheorghe Cioca, Andrew J. Bevacqua, Konstantinos M. Lahanas, Daniela Toma
DéposantE-L Management Corp.
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes:  Patentscope, Espacenet
Stable anhydrous formulation
WO 1999013859 A1
Résumé
The present invention is a cosmetic or pharmaceutical composition for topical application comprising a silicone gel and an effective amount of a biological active, especially a retinoid. The compositions permit stabilization of the biologically active agents.
Revendications  (Le texte OCR peut contenir des erreurs.)
What we claim is :
1. A cosmetic or pharmaceutical composition for topical application comprising a silicone gel and an effective amount of a retinoid.
2. The composition of claim 1 wherein the gel comprises an organopolysiloxane elastomer and a silicone oil vehicle.
3. The composition of claim 2 in which the elastomer is a reaction product of an organopolysiloxane having an unsaturated group bound to a terminal Si-atom and an organohydrogensiloxane, which reaction product is at least partially cured.
4. The composition of claim 2 in which the silicone oil is a low molecular weight dimethicone, trimethicone, or cyclomethicone .
5. The composition of claim 4 in which the silicone oil is phenyltrimethicone, or octamethylcyclotetrasiloxane .
6. The composition of claim 1 wherein the retinoid is retinol .
7. The composition of claim 1 which also comprises at least one antioxidant.
8. The composition of claim 7 wherein the antioxidant is an oil extract of green tea.
9. The composition of claim 1 which also comprises an effective amount of Vitamin C or a derivative thereof.
10. A cosmetic or pharmaceutical composition for topical application comprising a silicone gel, the gel comprising a (a) an organopolysiloxane elastomer which is a reaction product of an organopolysiloxane having an unsaturated group bound to a terminal Si-atom and an organohydrogensiloxane which reaction product is at least partially cured and (b)a silicone oil selected from the group consisting of a low molecular weight dimethicone, a trimethicone, or a cyclomethicone, combined with (c) an effective amount of a retinoid.
11. The composition of claim 10 wherein the retinoid is retinol .
12. The composition of claim 11 which also comprises an antioxidant .
13. The composition of claim 12 in which the antioxidant is an oil extract of green tea.
14. The composition of claim 10 which also comprises Vitamin C or a derivative thereof.
15. The composition of claim 10 which comprises retinol, an antioxidant, and Vitamin C or a derivative thereof.
16. The composition of claim 15 wherein the silicone oil is phenytrimethicone .
17. The composition of claim 15 wherein the silicone oil is octamethylcyclotetrasiloxane .
18. A method of stabilizing a retinoid which comprises mixing the retinoid with a silicone gel comprising an organopolysiloxane elastomer and a silicone oil vehicle.
19. The method of claim 18 wherein the elastomer is a reaction product of an organopolysiloxane having an unsaturated group bound to a terminal Si-atom and an organohydrogensiloxane which reaction product is at least partially cured.
20. The method of claim 18 wherein the silicone oil is a low molecular weight dimethicone, trimethicone, or cyclomethicone .
21. The method of claim 4 wherein the silicone oil is phenyltrimethicone, or octamethylcyclotetrasiloxane.
22. The method of claim 18 wherein the retinoid is retinol.
23. The method of claim 18 wherein the retinoid and silicone gel are also mixed with an antioxidant.
24. The method of claim 23 wherein the antioxidant is an oil extract of green tea.
25. A method of stabilizing a biologically active agent m a cosmetic or pharmaceutical composition which comprises mixing the agent with a silicone gel comprising an organopolysiloxane elastomer and a silicone oil vehicle.
26. The method of claim 25 wherein the silicone oil is a low molecular weight dimethicone, trimethicone or cyclomethicone .
27. The method of claim 26 wherein the silicone oil is phenyltrimethicone .
28. The method of claim 26 wherein the silicone oil is octamethylcyclotetrasiloxane .
29. The method of claim 25 wherein the composition also comprises an oil extract of green tea.
30. The method of claim 25 wherein the active agent is Vitamin C, or a derivative thereof.
31. A cosmetic or pharmaceutical composition comprising a water soluble biological active, wherein the active is stabilized in the composition by combination with a silicone gel comprising an organopolysiloxane elastomer and a silicone oil vehicle.
32. The composition of claim 15 which is anhydrous.
33. The composition of claim 15 wherein the active is Vitamin C.
34. A method of preventing or treating the symptoms of intrinsic aging or photoaging on the skin which comprises applying to the skin a composition of claim 1.
35. A method of preventing or treating the symptoms of intrinsic aging or photoaging on the skin which comprises applying to the skin a composition of claim 9.
36. A method of preventing or treating the symptoms of intrinsic aging or photoaging on the skin which comprises applying to the skin a composition of claim 10.
37. A method of preventing or treating the symptoms of intrinsic aging or photoaging on the skin which comprises applying to the skin a composition of claim 15.
38. A method of improving the texture or appearance of the skin which comprises applying to the skin a composition of claim 1.
39. A method of improving the texture or appearance of the skin which comprises applying to the skin a composition of claim 9.
40. A method of improving the texture or appearance of the skin which comprises applying to the skin a composition of claim 10.
41. A method of improving the texture or appearance of the skin which comprises applying to the skin a composition of claim 15.
Description  (Le texte OCR peut contenir des erreurs.)

STABLE ANHYDROUS FORMULATION

Field of the Invention

The present invention relates to cosmetic or pharmaceutical compositions comprising stable active agents. In particular, the invention relates to compositions in which active agents are stabilized by incorporation into a silicone gel.

Background of the Invention

In recent times, cosmetics have become developed beyond the concept of mere ornamentation for the face. Consumers now demand more from their makeup than simple color, coverage or moisturizing: it is now preferred that cosmetics provide some benefit to the skin, rather than just decorating it or making it feel softer. This consumer preference has resulted in the frequent use of biologically active ingredients, in many cosmetic products. In view of the now well-recognized damaging effects of sun exposure on the skin, particularly favored active components are those which can counteract or prevent those effects. These components include, for example, sunscreens, antioxidants, and anti-wrinkle agents.

One of the primary difficulties in employing actives in a formulation is the potential instability of the active once incorporated. The very reason for their use in the formulation, i.e., their biological activity, means that they are not inert, and are therefore potentially subject to reduction or loss of potency if not combined with the proper vehicle. A number of routinely encountered factors can readily inactivate a biologically active compound in a formulation before it even reaches the consumer. Such factors include, for example, oxygen, extreme temperatures, UV light, water, and lipid peroxidases. It is particularly difficult to avoid the effects of oxygen and UV light, which are of course virtually ubiquitous in nature. Although water can technically be avoided by anhydrous formulation, many of the very desirable actives are water soluble, making their incorporation into an anhydrous formulation problematic. Thus, there continues to be a need for development of a cosmetically acceptable vehicle which will be capable of readily incorporating water soluble actives, yet will protect the actives from environmental factors which rob them of their biological activity. The present invention provides a solution to this continuing problem.

Summary of the Invention The present invention provides an anhydrous cosmetic or pharmaceutical formulation for topical application to the skin, the formulation comprising a silicone gel, in combination with a safe and effective amount of one or more biologically active components. The invention also comprises a method of stabilizing a biologically active component, the method comprising combining the active component with a stabilizing amount of a silicone gel. A preferred active component is a retinoid.

In a preferred embodiment, the formulation also comprises an effective amount of an oil soluble antioxidant.

Detailed Description of the Invention

It has now been unexpectedly discovered that it is possible to stabilize biologically active materials by their combination with a silicone gel. The gels employed in the present invention comprise a vehicle in which an organopolysiloxane elastomer is dispersed. The vehicle can comprise any cosmetically acceptable silicone oil, or a combination of silicone oils. The silicone oil may be any volatile or non-volatile silicone oil, for example, any methylated linear or cyclic non-elastomeπc organopolysiloxane, or combinations thereof. Preferably, however, the vehicle is a lower molecular weight dimethicone, trimethicone, cyclomethicone, or a mixture of such oils. Preferred silicone oils useful as the gel vehicle m the present invention include, but are not limited to, phenyl trimethicone, or methylated cyclic organopolysiloxanes having ring sizes from 4 to 12, such as octamethylcyclotetrasiloxane or decamethylpentasiloxane . The gel is prepared by dispersing in the vehicle an organopolysiloxane elastomer. An elastomer is generally a chain polymer having a degree of cross-linking sufficient to provide a rubber-like material. In the present gel, the elastomer is an at least partially crosslinked or at least partially cured hetero-chain elastomer. Particularly preferred are those which are at least partially cured addition reaction products, i.e., hydrosilation products, or addition polymerization products, of an organopolysiloxane having unsaturated groups, such as vinyl or allyl, preferably bonded to at least one terminal silicon atom, and another silicone compound capable of participation in the addition reaction, such as an organohydrogenpolysiloxane . Suitable organopolysiloxane elastomers, having a three- dimensional cross-linked structure, are described, for example, m US Patent No. 5,266,321, the contents of which are incorporated herein by reference. However, other suitable elastomer materials are disclosed in, for example, US Patent Nos . 4,980,167 and 4,742,142. A preferred organopolysiloxane is one which is at least partially crosslinked, or is an at least partially cured hetero-chain elastomer. In one preferred embodiment, the organopolysiloxane elastomer is one which is one which is an at least partially cured addition reaction products, i.e., hydrosilation products, or addition polymerization products, of an organopolysiloxane having unsaturated groups, such as vinyl or allyl, preferably bonded to at least one terminal Si atom, and another silicon compound capable of participation m the addition reaction, such as an organohydrogen polysiloxane .

The chosen elastomer is dispersed in the vehicle by known homogenization techniques. The elastomer dispersed in the vehicle provides a soft, stable viscous gel, or gel-like material. Alternatively, the gel can be purchased premade, with the elastomer already dispersed in the vehicle. Such products are available under the name Gransil, for example Gransil GCM or Gransil PM, from Grant Industries, Inc., Elmwood Park, New Jersey. The amounts of elastomer and vehicle may vary, depending on the desired viscosity, but generally should be in the range of 5-40% elastomer and 60- 95% vehicle.

The gel so prepared can be directly combined with the desired active agent. In a preferred embodiment, the active agent is a retinoid, e.g., Vitamin A(retmol), Vitamin A aldehyde (retinal) , Vitamin A acid (retmoic acid) and derivatives of these compounds, for example, retinyl palmitate, retinyl acetate and the like. Retmoids are readily miscible with the silicone gel, and can be mixed directly into the gel, or as dissolved in an oil-miscible solvent. The retinoid is added to the gel m an amount sufficient to produce about 0.001-5%, more preferably about 0.01-2%, concentration by weight of the total composition to be applied. Although retmoids, especially retmol, are particularly preferred active agents to be stabilized by this method, it will be readily recognized by the skilled artisan that other active agents, such as Vitamin E and derivatives, long-chain alpha hydroxy acids, ceramides, or skin lipids to enhance barrier function can also benefit from combination with a silicone gel.

In addition to the oil-soluble or lipophilic active agents, however, it has surprisingly been discovered that the silicone gel system can also serve to stabilize water- soluble actives. Although not soluble in the silicone gel, it is possible to simply disperse the water-soluble active in the gel, and thereby provide the stabilizing effect which also protects the oil-soluble active. In a preferred embodiment, the water-soluble active is Vitamin C, or a water-soluble derivative thereof, which has useful cosmetic/dermatological properties, such as stimulating collagen synthesis, but which is generally very unstable in formulation. Other useful water-soluble actives which can also be employed are, for example, water soluble preservatives and antioxidants ; skin conditioning agents, for example, humectants, such as hyaluronic acid salts, hydrogels, or glycerol or elastin; collagen; alpha-and beta- hydroxy acids; or milk protein. In a preferred embodiment of this invention, the composition comprises at least one oil soluble active and at least one water soluble active. In a particularly preferred embodiment, the composition comprises the combination of retinol with Vitamin C, which has many benefits to the skin, including collagen stimulation, the Vitamin C being present in an amount of from about 0.1-20% by weight of the total composition.

Although the gel itself is sufficient to stabilize a susceptible active agent against oxygen degradation, it may be desirable to supplement this property with one or more additional antioxidants, preferably lipophilic antioxidants. Examples of useful antioxidants include Vitamin E and its derivatives, BHT, BHA, NDGA, propyl gallate, and the like. In a preferred embodiment, the antioxidant employed is an oil extract of green tea, this type of extract being more stable than aqueous green tea extracts. The oil soluble green tea extract is employed in an amount of from about 0.01-15% by weight of the total composition. Additional components may also be added to the composition, depending upon the intended use of the final product. Examples of such additional components may include, but are not limited to, sunscreens, fragrance, preservatives, emollients, viscosity modifying agents, pigments, and dispersants. The active-containing silicone gel composition can be used as is, or can be further diluted by combination with an appropriate solvent or vehicle, to achieve the desired consistency for application. The vehicle or solvent may be any anhydrous base in which the silicone gel composition is compatible and miscible.

Examples of appropriate bases are volatile or non volatile oils. Suitable volatile oils include cyclic and linear silicones, such as cyclomethicone, octamethylcyclotetrasiloxane, and decamethylcyclopentasiloxane; or straight or branched chain hydrocarbons having from 8-20 carbon atoms, such as decane, dodecane, tridecane, tetradecane, and C8-20 isoparaffins . Suitable non-volatile oils include vegetable oils, carboxylic acid esters, animal oils, glyceryl esters, non- volatile silicones, and nonvolatile hydrocarbons.

Particularly preferred are the volatile cyclic silicones. It is desirable in many cases, however, to retain much of the gel-like consistency of the original composition; therefore, in such a composition, the added base is preferably used in an amount of no more than about 10-15% of the total weight of the composition.

The preferred composition of the present invention is one in which the active component is a retinoid, and most preferably, one in which the retinoid is retinol. These compounds have a number of useful skin-enhancing activities, such as treatment of the symptoms of intrinsic aging, e.g., lines and wrinkles, improvement of skin texture and appearance, prevention or treatment of the symptoms of photoaging, and acne treatment. However, they are extremely susceptible to degradation by a number of external sources, thereby creating significant difficulties in formulating them in such a way as to retain their activity, and to permit the formulations to retain activity over a prolonged storage period. The present retinoid compositions, however, eliminate the need for special formulating conditions, such as dark rooms, nitrogen purging, or separate packaging of the active agent and the vehicle. In preparing the present compositions, the components are simply mixed together under standard conditions. The compositions so prepared show a remarkable stability over time, with the retention of at least about 85%, and preferably at least about 90% of the original activity, after a storage period of 8 weeks at room temperature, and as much as 80% or more retained activity even when stored at elevated temperatures (40°C) for 8 weeks. The present invention will be further illustrated by the following non-limiting examples.

Example I A composition of the invention is prepared as follows:

Materials Weight %

Phase I

Gransil PM-gel (Grant Industries) 85.00*

Phase II green tea oil extract (LipoChemical) 9.90 retinol 50P base (BASF) 0.10** Phase III

Ascorbic acid USC-FCC 5.00

Xomprising phenyltrimethicone (70% ) and organopolysiloxane (30%) **50% solution in Tween 20

Preparation :

Phase I is weighed into a primary mixing kettle. In an auxiliary kettle, the Phase II components are mixed under propeller mixer agitation until the solids are completely dissolved; the mixture at this point is slightly cloudy. The phase III component is then sprinkled over the Phase II materials, while mixing under propeller mixer agitation.

The uniform dispersion of the combined Phases II and III is confirmed by placing a small sample between glass slides and checking for undispersed ascorbic acid. When the combined Phases II and III are well-dispersed, they are added to Phase I in the primary mixing kettle under mixer agitation, until the combined phases are uniform. The mixture is removed from the kettle through a nylon mesh filter bag, and stored in polyethylene-lined storage containers.

Example II

Compositions prepared according to Example I are then evaluated for their ability to retain activity over a variety of time and temperature storage conditions. In the first instance, the amount of retinol in the compositions is determined, by HPLC, shortly after preparation, and at intervals for up to 8 weeks thereafter, at temperatures of 4°C, 25°C, and 40°C. The results, showing amount of retinol activity remaining, are shown in Table I. Table I

These results show that at low and room temperature conditions, the compositions can retain up to about 90% or more activity after 8 weeks of storage, and even under extreme heat conditions, retains up to about 80% of its initial activity, thereby demonstrating the stabilizing effect of the silicone gel on retinol activity.

The stability of the ascorbic acid in the composition is also evaluated at 4°C, 25°C, and 40°C. At the end of eight weeks of storage, the compositions show 99%, 96% and 95% retention of ascorbic acid activity, indicating a high level of stabilization of this water-soluble active, even in a non-aqueous formulation.

Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
WO1998000103A1 *16 mai 19978 janv. 1998Unilever PlcVitamin c delivery system
WO1998000105A1 *10 juin 19978 janv. 1998Unilever PlcCosmetic compositions containing a siloxane elastomer
EP0723776A1 *10 janv. 199631 juil. 1996L'orealCosmetic composition containing a silicone compound and a fatty acid ester
EP0742005A2 *17 avr. 199613 nov. 1996Unilever PlcSkin care compositions containing fatty acid amides and retinol or retinyl ester
EP0790055A1 *30 janv. 199720 août 1997L'orealUse of a solid elastomeric organopolysiloxane in a fatty phase for the preparation of a composition or in a make-up or skin care composition for giving a matt appearance to the skin
EP0850643A1 *12 déc. 19971 juil. 1998L'orealMake up or personal care composition which does not rub off and which comprises a solid elastomeric organopolysiloxane and a fatty phase
FR2732595A1 * Titre non disponible
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
WO2004010966A1 *25 juil. 20025 févr. 2004Lion CorporationExternal preparation
WO2014149140A2 *21 mars 201425 sept. 2014Julius ZecchinoDelivery system having stabilized ascorbic acid and other actives
WO2014149140A3 *21 mars 201427 nov. 2014Julius ZecchinoDelivery system having stabilized ascorbic acid
DE19962369A1 *23 déc. 199928 juin 2001Beiersdorf AgComposition of ascorbyl compound and catechin, or extract containing it, useful for improving barrier properties of skin
EP1096922A1 *25 juin 19999 mai 2001Shaklee CorporationImproved stable topical ascorbic acid compositions
EP1096922A4 *25 juin 199919 mai 2004Shaklee CorpImproved stable topical ascorbic acid compositions
EP2580304A4 *10 juin 20118 juil. 2015Polymer Dynamix LlcFlame retardant material having enhanced pull through lubricity
US6039935 *17 févr. 199921 mars 2000Elizabeth Arden Company, Division Of Conopco, Inc.Sunscreen compositions
US622889419 mars 19998 mai 2001Enhanced Derm Technologies, Inc.Softgel-compatible composition containing retinol
US776359524 oct. 200827 juil. 2010Lion CorporationMethod of treatment of skin with external preparation composition
US777221410 juil. 200110 août 2010The Procter & Gamble CompanyEmulsion cosmetic compositions comprising an emulsifying crosslinked siloxane elastomer
US792809023 oct. 200919 avr. 2011Lion CorporationExternal preparation composition
US822236322 sept. 200817 juil. 2012Dow Corning CorporationSilicone organic elastomer gels from organopolysiloxane resins
US827384020 mars 200725 sept. 2012Dow Corning CorporationSilicone polyether elastomer gels
US85410115 juin 201224 sept. 2013Dow Corning CorporationSilicone organic elastomer gels from organopolysiloxane resins
US892078320 mars 200730 déc. 2014Dow Corning CorporationSilicone-organic elastomer gels
US893903320 juil. 201127 janv. 2015Schlumberger Technology CorporationFlow meter system and method for measuring an amount of liquid in a largely gaseous multiphase flow
US20140219934 *22 janv. 20147 août 2014Sandra SenzonBotanical tooth whitener composition and method for treating discolored or stained teeth
US20140348873 *22 mai 201327 nov. 2014Professional Compounding Centers Of AmericaUrea-Silicone Gel for Hyperkeratosis Treatment
US20140350106 *22 mai 201327 nov. 2014Professional Compounding Centers Of AmericaUrea Silicone Gel for Scars and Hydration Treatment and Method of Using Same
Classifications
Classification internationaleA61K8/30, A61K8/00, A61K8/58, A61K47/38, A61Q19/00, A61K8/97, A61K8/891, A61K8/72, A61K47/10, A61K8/67, C08L83/04, A61K8/89
Classification coopérativeA61Q19/004, A61K8/891, A61K8/671, A61K2800/31, A61K8/585, A61Q19/00, A61Q19/08, A61K2800/522
Classification européenneA61Q19/00, A61K8/67C, A61K8/891, A61K8/58C, A61Q19/00K, A61Q19/08
Événements juridiques
DateCodeÉvénementDescription
25 mars 1999AKDesignated states
Kind code of ref document: A1
Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW
25 mars 1999ALDesignated countries for regional patents
Kind code of ref document: A1
Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG
27 avr. 1999ENPEntry into the national phase in:
Ref country code: CA
Ref document number: 2270073
Kind code of ref document: A
Format of ref document f/p: F
Ref document number: 2270073
Country of ref document: CA
11 mai 1999WWEWipo information: entry into national phase
Ref document number: 1998945997
Country of ref document: EP
15 mai 1999WWEWipo information: entry into national phase
Ref document number: 1019997004324
Country of ref document: KR
17 mai 1999ENPEntry into the national phase in:
Ref country code: JP
Ref document number: 1999 517977
Kind code of ref document: A
Format of ref document f/p: F
2 juin 1999121Ep: the epo has been informed by wipo that ep was designated in this application
3 nov. 1999WWPWipo information: published in national office
Ref document number: 1998945997
Country of ref document: EP
13 janv. 2000REGReference to national code
Ref country code: DE
Ref legal event code: 8642
25 nov. 2000WWPWipo information: published in national office
Ref document number: 1019997004324
Country of ref document: KR
3 avr. 2001WWWWipo information: withdrawn in national office
Ref document number: 1998945997
Country of ref document: EP
11 sept. 2003WWWWipo information: withdrawn in national office
Ref document number: 1019997004324
Country of ref document: KR